SCHEMBL3223586

SCHEMBL3223586

Cc1cccnc1N1CCN(S(=O)(=O)c2ccc3ccccc3c2)CC1

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 4/20 0.72
KDM4E B2RXH2 2/20 0.58
ALDH1A1 P00352 1/20 0.58
HPGD P15428 1/20 0.58
PKM P14618 4/20 0.57
SMN1; SMN2 Q16637 3/20 0.57
LMNA P02545 3/20 0.57
HTT P42858 1/20 0.57
F13A1 P00488 1/20 0.57
TGM2 P21980 1/20 0.57
TGM1 P22735 1/20 0.57
TGM3 Q08188 1/20 0.57
GAA P10253 1/20 0.56
GBA1 P04062 1/20 0.55
MCOLN3 Q8TDD5 3/20 0.54
TSHR P16473 1/20 0.54
ABL1 P00519 1/20 0.53
BCR P11274 1/20 0.53
MEN1 O00255 1/20 0.53
KMT2A Q03164 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3210941 0.87 HSD11B1 (0.72) HSD11B1KDM4EALDH1A1HPGDPKM
SCHEMBL3226054 0.84 HSD11B1 (0.73) HSD11B1SMN1; SMN2F13A1TGM2TGM1
SCHEMBL3223804 0.83 HSD11B1 (0.79) HSD11B1ALDH1A1SMN1; SMN2LMNAF13A1
SCHEMBL3213169 0.83 HSD11B1 (1.00) HSD11B1
SCHEMBL2963619 0.82 TSHR (0.71) HSD11B1KDM4EPKMSMN1; SMN2LMNA
SCHEMBL3217991 0.81 HSD11B1 (0.81) HSD11B1KDM4EF13A1TGM2TGM1
SCHEMBL3216059 0.81 HSD11B1 (0.50) HSD11B1KDM4EALDH1A1HPGDLMNA
SCHEMBL23051855 0.81 SMN1; SMN2 (0.71) HSD11B1PKMSMN1; SMN2LMNAHTT
SCHEMBL3213203 0.81 TDP1 (0.70) ALDH1A1PKMSMN1; SMN2LMNAHTT
SCHEMBL3209872 0.80 HSD11B1 (0.64) HSD11B1KDM4EHPGDSMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100029648-A1 11-Beta HSD1 Inhibitors XIANG JASON SHAOYUN 2010-02-04 US disclosed
US-7632838-B2 11-beta HSD1 inhibitors WYETH (US) 2009-12-15 US disclosed
US-20070219198-A1 11-Beta HSD 1 inhibitors WYETH (US) 2007-09-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100029648-A1 11-Beta HSD1 Inhibitors HSD11B1, HSD3B1, HSD11B2 HSD11B1 1/4885KDM4E 1296/4885ALDH1A1 116/4885
US-20070219198-A1 11-Beta HSD 1 inhibitors HSD11B1, HSD11B2, HSD3B1 HSD11B1 1/4885KDM4E 1360/4885ALDH1A1 123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.